摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-diamino-9H-xanthen-9-one | 71641-67-3

中文名称
——
中文别名
——
英文名称
3,6-diamino-9H-xanthen-9-one
英文别名
3,6-diaminoxanthen-9-one
3,6-diamino-9H-xanthen-9-one化学式
CAS
71641-67-3
化学式
C13H10N2O2
mdl
——
分子量
226.235
InChiKey
BIYCVSAOMJBWNN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    17
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    78.3
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,6-diamino-9H-xanthen-9-one六氟磷酸钾草酰氯 、 sodium hydride 作用下, 以 四氢呋喃四氯化碳乙腈 为溶剂, 反应 50.0h, 生成
    参考文献:
    名称:
    Synthesis of new cyclic aromatic carbene ligands bearing remote amino groups and their palladium(ii) complexes
    摘要:
    新开发了一类具有远程氨基官能团的新型环状芳香羰基配体。钯零价对氯化物前体的氧化加成反应生成了相应的钯二价配合物,其羰基配体的供电子能力被证明比传统NHC配体更强。
    DOI:
    10.1039/c2cc33510g
  • 作为产物:
    描述:
    2-氯-4-硝基苯甲酸硫酸potassium carbonate 、 tin(ll) chloride 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 2.0h, 生成 3,6-diamino-9H-xanthen-9-one
    参考文献:
    名称:
    玫瑰孟加拉类似物作为SecA抑制剂的设计,合成和生物学评估
    摘要:
    SecA是细菌Sec依赖性分泌途径的关键组成部分,是探索新型抗菌药物的有吸引力的靶标。从我们以前的研究中发现,玫瑰孟加拉(RB)是一种多卤代荧光素衍生物,是一种有效的SecA抑制剂。在这里,我们描述了通过系统解剖RB设计的23种RB类似物的合成和构效关系(SAR)。这些类似物的评估使我们能够建立SecA抑制的初始SAR。这些SecA抑制剂的抗微生物作用已在使用大肠杆菌和枯草芽孢杆菌的实验中得到证实。
    DOI:
    10.1002/cmdc.201300216
点击查看最新优质反应信息

文献信息

  • NEAR-IR GLUCOSE SENSORS
    申请人:Profusa, Inc.
    公开号:US20180179233A1
    公开(公告)日:2018-06-28
    Glucose-sensing luminescent dyes, polymers, and sensors are provided. Additionally, systems including the sensors and methods of using these sensors and systems are provided.
    提供了葡萄糖感应荧光染料、聚合物和传感器。此外,还提供了包括传感器的系统以及使用这些传感器和系统的方法。
  • Design, Synthesis and Biological Evaluation of Rose Bengal Analogues as SecA Inhibitors
    作者:Jianmei Cui、Jinshan Jin、Ying-Hsin Hsieh、Hsiuchin Yang、Bowen Ke、Krishna Damera、Phang C. Tai、Binghe Wang
    DOI:10.1002/cmdc.201300216
    日期:2013.8
    SecA, a key component of bacterial Sec‐dependent secretion pathway, is an attractive target for exploring novel antimicrobials. Rose bengal (RB), a polyhalogenated fluorescein derivative, was found from our previous study as a potent SecA inhibitor. Here we describe the synthesis and structure–activity relationships (SAR) of 23 RB analogues that were designed by systematical dissection of RB. Evaluation
    SecA是细菌Sec依赖性分泌途径的关键组成部分,是探索新型抗菌药物的有吸引力的靶标。从我们以前的研究中发现,玫瑰孟加拉(RB)是一种多卤代荧光素衍生物,是一种有效的SecA抑制剂。在这里,我们描述了通过系统解剖RB设计的23种RB类似物的合成和构效关系(SAR)。这些类似物的评估使我们能够建立SecA抑制的初始SAR。这些SecA抑制剂的抗微生物作用已在使用大肠杆菌和枯草芽孢杆菌的实验中得到证实。
  • [EN] ROSAMINE DERIVATIVES AS AGENTS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE ROSAMINE COMME AGENTS POUR LE TRAITEMENT D'UN CANCER
    申请人:CANCER RES INITIATIVES FOUNDAT
    公开号:WO2010033011A1
    公开(公告)日:2010-03-25
    The present invention relates to a new class of rosamine derivatives, in one embodiment, the compounds have the structure (I) or any pharmaceutically acceptable salt or solvate thereof, wherein: R1 represents aryl, Het1 or C1-6 alkyl, which latter group is optionally substituted by aryl or Het2; R2a and R2b together form C3.8n-alkylene, which alkylene group is optionally substituted by one or more substituents selected from halo, C1-4 alkyl, C(O)OH and C(O)O-C1-4, alkyl.and which alkylene group is optionally interrupted by X1; R3a and R3b together form C3-6 /7-alkylene, which alkylene group is optionally substituted by one or more substituents selected from halo, C1-4 alkyl, C(O)OH and C(O)O-C1-4 alkyl, and which alkylene group is optionally interrupted by X2; X1 and X2 independently represent O, S, or NR4; R4 represents, independently at each occurrence, H, C(O)OR5, C(0)R6a, C(O)N(R6b)R6c or C1-6, alkyl, which latter group is optionally substituted by one or more substituents selected from halo, aryl and Het3 or is substituted by a single C(0)0R1a group; R4a represents H or C1-4 alkyl; R5 represents aryl, Het4 or C1-6 alkyl optionally substituted by one or more substituents selected from halo, aryl and Het5; R5e to R6d independently represent H or R5; each aryl independently represents a C6-10 carbocyclic aromatic group, which group may comprise either one or two rings and may be substituted by one or more substituents selected from halo, CN, C1-6 alkyl (which latter group is optionally substituted by one or more substituents selected from halo, OR7, phenyl, naphthyl and Het6) and OR8; R7 and R8 independently represent H, C1-4 alkyl (optionally substituted by one or more halo groups or by a single phenyl or C(O)OR8a substituent), Het7, phenyl or naphthyl; R8a represents H or C1-4 alkyl; Het1 to Het7 independently represent 5- to 10-membered aromatic, fully saturated or partially unsaturated heterocyclic groups containing one or.more heteroatoms selected from oxygen, nitrogen and/or sulfur, which heterocyclic groups may comprise one or two rings and may be substituted by one or more substituents selected from Halo, CN, C1-6 alkyl (which latter group is optionally substituted by one or more substituents selected from halo, OR9 and phenyl) and OR10; R9 and R10 independently represent H, C1-4 alkyl or phenyl; unless otherwise specified, alkyl groups are optionally substituted by one or more halo atoms; and A' represents a pharmaceutically acceptable anion. Also disclosed are methods for making and using ' compounds as well as pharmaceutical compositions.
    本发明涉及一类新的罗萨明衍生物,其中在一个实施例中,化合物具有结构(I)或其任何药学上可接受的盐或溶剂,其中:R1代表芳基、Het1或C1-6烷基,后者可由芳基或Het2取代;R2a和R2b一起形成C3.8n-烷基,该烷基可由卤素、C1-4烷基、C(O)OH和C(O)O-C1-4烷基中选择的一个或多个取代基取代,并且该烷基可由X1中断;R3a和R3b一起形成C3-6/7-烷基,该烷基可由卤素、C1-4烷基、C(O)OH和C(O)O-C1-4烷基中选择的一个或多个取代基取代,并且该烷基可由X2中断;X1和X2独立地表示O、S或NR4;R4在每次出现时独立地表示H、C(O)OR5、C(0)R6a、C(O)N(R6b)R6c或C1-6烷基,后者可由卤素、芳基和Het3中选择的一个或多个取代基取代,或者由单个C(0)0R1a基团取代;R4a表示H或C1-4烷基;R5代表芳基、Het4或C1-6烷基,可由卤素、芳基和Het5中选择的一个或多个取代基取代;R5e到R6d独立地表示H或R5;每个芳基独立地表示一个含有6-10个碳环芳族的芳基,该芳基可能包含一个或两个环,并且可能被一个或多个取代基如卤素、CN、C1-6烷基(后者可由一个或多个取代基如卤素、OR7、苯基、萘基和Het6取代)和OR8取代;R7和R8独立地表示H、C1-4烷基(可由一个或多个卤素基或单个苯基或C(O)OR8a取代基取代)、Het7、苯基或萘基;R8a表示H或C1-4烷基;Het1到Het7独立地表示含有一个或多个异氧、氮和/或硫的芳族、完全饱和或部分不饱和的杂环基,这些杂环基可能包含一个或两个环,并且可能被一个或多个取代基如卤素、CN、C1-6烷基(后者可由一个或多个取代基如卤素、OR9和苯基取代)和OR10取代;R9和R10独立地表示H、C1-4烷基或苯基;除非另有规定,烷基可能由一个或多个卤素原子取代;A'表示药学上可接受的阴离子。还公开了制备和使用该化合物以及制药组合物的方法。
  • COMBINATORIAL ROSAMINE LIBRARY AND USES THEREOF
    申请人:Chang Young-Tae
    公开号:US20080124751A1
    公开(公告)日:2008-05-29
    The present invention relates to a rosamine derivative compound, as described herein, having the following structure: Also disclosed are methods of making such compounds and for using them for detection and imaging.
    本发明涉及一种罗萨明衍生物化合物,具有以下结构:此外,还公开了制备这种化合物的方法以及将其用于检测和成像的方法。
  • COMBINATORIAL ROSAMINE LIBRARY TO DETECT CELL-STATE SWITCHING
    申请人:CHANG Young-Tae
    公开号:US20090227467A1
    公开(公告)日:2009-09-10
    The present invention relates to the use of rosamine derivative compounds, as described herein, in detecting differentiated forms of a cell type of interest in a sample and in screening for compounds which inhibit differentiation of the cell type of interest. The candidate compound has the following structure:
    本发明涉及使用如下所述的罗萨明衍生物化合物在样本中检测感兴趣的细胞类型的分化形式,并筛选抑制该细胞类型分化的化合物。候选化合物具有以下结构:
查看更多